MTHFD2 is a metabolic enzyme and plays an important regulatory role in tumorigenesis, including acute myeloid leukemia (AML) [32], breast cancer [33], and renal cell carcinoma (RCC) [34]. Here, MTHFD2 is linked to hereditary clear cell renal cell carcinoma.